Artwork
iconShare
 
Manage episode 521419685 series 3635277
Content provided by Dr. William Wallace. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Dr. William Wallace or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.

Magnesium salts are often marketed as if they target specific tissues - i.e., “threonate for the brain,” “glycinate for calm,” “taurate for the heart.” Part 2 breaks down what the evidence actually shows: animal studies demonstrating tissue differences that have never been replicated in humans, cognitive and sleep trials where multiple forms show benefit, and meta-analytic data indicating what really drives long-term outcomes.

The goal: clarify the real distinctions between magnesium forms, ligand effects, and dose requirements so listeners can understand what truly determines magnesium’s impact in humans.

00:00 Introduction to Magnesium Forms

00:22 Zooming Out: Broader Human Data

01:08 Systematic Reviews and Meta-Analyses

02:10 Key Findings on Magnesium Benefits

04:05 Understanding Magnesium Salts and Ligands

07:13 Practical Applications and Recommendations

09:32 Conclusion and Final Thoughts

  • Doi: 10.1186/s40795-016-0121-3
  • PMID: 11550076
  • PMID: 31330811
  • PMID: 39252819
  • PMID: 26519439
  • PMID: 34111673
  • PMID: 23853635
  • doi: 10.3390/nu9050429
  • PMID: 39009081
  continue reading

Chapters

1. Revisiting Forms And Absorption (00:00:00)

2. Human Trials Show Broad Benefits (00:00:51)

3. Cognitive Evidence And Dose Ranges (00:02:10)

4. Separating Magnesium From The Ligand (00:04:00)

5. What Predicts Long‑Term Benefits (00:06:06)

6. Practical Buying And Dosing Advice (00:07:13)

7. Final Takeaways And Listener Requests (00:09:10)

69 episodes